May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
April 08, 2010
US Oftalmi has issued a nationwide voluntary recall of all its over-the-counter Camolyn eye drops and Fisiolin nasal drops in 15mL bottles due to conditions at the manufacturing facility that cannot assure the sterility of the products.
August 24, 2009
Resolvyx Pharmaceuticals announced positive data from its Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.
May 04, 2009
Restasis (cyclosporine 0.05%, from Allergan) ophthalmic emulsion is now available in a 60-count package (two trays of 30 vials) that provides patients with a 30-day supply.
October 29, 2008
Aton Pharma has launched Lacrisert (hydroxypropyl cellulose ophthalmic insert) for the treatment of moderate-to-severe dry eye syndromes.